interRAI Transforms Mental Health Care with Comprehensive Suite of Assessment Instruments
August 09, 2023 09:00 ET
|
interRAI
interRAI: Speaking one language for high quality care worldwide WATERLOO, Ontario, Aug. 09, 2023 (GLOBE NEWSWIRE) -- In a recently-published ebook based on a Special Issue of Frontiers in...
Morning Light Therapy for Tourette's Disorder
August 01, 2023 09:00 ET
|
Brain & Behavior Research Foundation
New York, Aug. 01, 2023 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Morning Light Therapy for Tourette's Disorder” on Tuesday, August 8, 2023,...
Brain & Behavior Research Foundation Honors Innovative Psychiatric Researchers
July 31, 2023 11:50 ET
|
Brain & Behavior Research Foundation
New York, July 31, 2023 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) today announced the winners of its 2023 Klerman and Freedman Prizes, recognizing exceptional clinical...
Advanced FDA Cleared Magstim Horizon 3.0 Transcranial Magnetic Stimulation Now Available in United Kingdom
July 07, 2023 07:09 ET
|
Magstim EGI
WHITLAND, United Kingdom, July 07, 2023 (GLOBE NEWSWIRE) -- The advanced and FDA-cleared Magstim Horizon 3.0 transcranial magnetic stimulation (TMS) system is now UKCA registered and available for...
What Genetics is Telling Us About Substance Use Disorders - A Free Webinar from the Brain & Behavior Research Foundation
June 29, 2023 14:55 ET
|
Brain & Behavior Research Foundation
New York, June 29, 2023 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “What Genetics is Telling Us About Substance Use Disorders” on Tuesday,...
Mount Sinai Creates Transformational New Model of Behavioral Health Care With New State-of-the-Art $140 Million Center
June 08, 2023 16:24 ET
|
Mount Sinai Health System
NEW YORK, June 08, 2023 (GLOBE NEWSWIRE) -- Mount Sinai Health System today hosted a ribbon-cutting ceremony for the newly constructed Mount Sinai-Behavioral Health Center, located at 45 Rivington...
ConSynance Therapeutics Reports Positive Phase 1 Results for CSTI-500 in Prader-Willi Syndrome Patients
May 30, 2023 10:00 ET
|
ConSynance Therapeutics
RENSSELAER, New York, May 30, 2023 (GLOBE NEWSWIRE) -- ConSynance Therapeutics, Inc., an emerging biopharmaceutical firm focused on developing novel therapies for rare central nervous system (CNS)...
Schizophrenia Drugs Market Size to Witness Healthy Valuation of US$ 12.6 Billion at 5.6% CAGR by 2032 | Market.us Report
May 25, 2023 07:54 ET
|
Market.Us
New York, May 25, 2023 (GLOBE NEWSWIRE) -- As per this latest study by Market.us, The global Schizophrenia Drugs Market was valued at US$ 7.4 Bn in 2022. It is projected to expand at a CAGR of 5.6%...
Nexstim’s Quality System and NBS 6 Receive MDR Certification in the EU
May 17, 2023 07:00 ET
|
Nexstim Oyj
Press release, Helsinki, 17 May 2023 at 2 PM (EEST) Nexstim’s Quality System and NBS 6 Receive MDR Certification in the EU Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received...
How the Brain's Dopamine Circuitry Helps Regulate Cognitive Flexibility and Reward-Seeking
May 02, 2023 12:39 ET
|
Brain & Behavior Research Foundation
New York, May 02, 2023 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “How the Brain's Dopamine Circuitry Helps Regulate Cognitive Flexibility and...